Loading fund overlap…
17 of 232 unique stocks in common · Jaccard: 7.3%
A weighted portfolio overlap of 21.68% indicates a moderate overlap (a meaningful shared core). This means that out of every ₹100 you invest across these two schemes, approximately ₹21.68 is allocated to the exact same companies at the same relative proportions. The schemes share 17 common holdings.
The largest overlapping asset in their portfolios is Infosys, which commands a weight of 3.76% in SBI Nifty 50 ETF and 7.13% in UTI Nifty500 Shariah Index Fund. Holding both schemes increases your concentration in Infosys rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in SBI | in UTI |
|---|---|---|
| InfosysIT - Software | 3.76% | 7.13% |
| Tata Consultancy ServicesIT - Software | 2.13% | 4.04% |
| Hindustan UnileverDiversified FMCG | 1.77% | 3.35% |
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | 1.76% | 3.34% |
| Hindalco IndustriesNon - Ferrous Metals | 1.51% | 2.86% |
| Ultratech CementCement & Cement Products | 1.26% | 2.38% |
| HCL TechnologiesIT - Software | 1.15% | 2.19% |
| Asian PaintsConsumer Durables | 1.12% | 2.11% |
| Oil & Natural Gas CorporationOil | 0.95% | 1.80% |
| Nestle IndiaFood Products | 0.94% | 1.78% |
| Tech MahindraIT - Software | 0.87% | 1.65% |
| TrentRetailing | 0.87% | 1.64% |
| Tata Motors Passenger VehiclesAutomobiles | 0.76% | 1.44% |
| CiplaPharmaceuticals & Biotechnology | 0.73% | 1.38% |
| Dr. Reddy's LaboratoriesPharmaceuticals & Biotechnology | 0.73% | 1.39% |
| Tata Consumer ProductsAgricultural Food & Other Products | 0.71% | 1.34% |
| Max Healthcare InstituteHealthcare Services | 0.66% | 1.26% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.